medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2014, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2014; 12 (2)

Demodecidosis: A review of current trends

Jasso OJC, Domínguez CJ, Hojyo TMT, Díaz GJM

Language: Spanish
References: 26
Page: 122-127
PDF size: 284.25 Kb.


ABSTRACT

The term demodecidosis spans cutaneous diseases caused by mites of the Demodex genus, including D. folliculorum and D. brevis, both common parasites of the pilosebaceous units of humans. D. folliculorum has also been implicated in the pathogenesis of rosacea and Pityriasis folliculorum.
This review addresses demodecidosis as a separate entity from rosacea and assesses proposed eradication therapies.


REFERENCES

  1. Lazaridou E, Giannopoulou C, Fotiadou C, Vakirlis E, Trigoni A et al. “The potential role of microorganisms in the development of rosacea”. JDDG 2011; 9: 21-25.

  2. Kaufmann-Wolf M. “Uber regelma Biges Vorkommen von Demodex folliculorum in den Pusteln von Rosacea pustulosa”. Dermatol Wochenschr 1925; 30: 1095-1103.

  3. Desch CE, Nutting WB. “Morphology and functional anatomy of Demodex folliculorum (Simon) of man”. Acarologia (Paris) 1977; 19: 422-462.

  4. Akilov OE, Mumcuoglu KY. “Immune response in demodicosis”. J Eur Acad Dermatol Venereol 2004; 18: 440-444.

  5. Forton F. “Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link”. J Eur Acad Dermatol Venereol. Jan 2012; 26(1): 19-28.

  6. Akilov OE, Mumcuoglu KY. “Association between human demodicidosis and HLA class I”. Exp Dermatol 2003; 28: 70-73.

  7. Seyhan ME, Karincaoglu Y, Bayram N, et al. Density of Demodex folliculorum in Haematological Malignancies. J Int Med Res 2004; 32: 411-415.

  8. Karincaoglu Y, Esrefoglu Seyhan M, Bayram N, et al. “Incidence of Demodex folliculorum in patients with end stage chronic renal failure”. Ren Fail 2005; 27: 495-499.

  9. Forton F, Germaux M-A, Brasseur T, Liever A, Laporte M, et al. “Demodecosis and Rosacea: epiemiology and significance in daily dermatologic practice”. J Am Acad Dermatol 2005; 52: 74-87.

  10. Vollmer RT. “Demodex-associated folliculitis”. Am J Dermatopathol 1996; 18: 589-591.

  11. Aroni K, Tsagroni E, Lazaris AC, et al. “Rosacea: a clinicopathological approach”. Dermatology 2004; 209: 177-182.

  12. Georgala S, Katoulis AC, Kylafis GD, et al. “Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea”. J Eur Acad Dermatol Venereol 2001; 15: 441-444.

  13. Whitfeld M, Gunasingam N, Leow LJ, et al. “Staphylococcus epidermidis: a possible role in the pustules of rosacea”. J Am Acad Dermatol 2011; 64: 49-52.

  14. Dahl MV, Ross AJ, Schlievert PM. “Temperature regulates bacterial protein production: possible role in rosacea”. J Am Acad Dermatol 2004; 50: 266-272.

  15. Zhao YE, Guo N, Wu LP. “The effect of temperature on the viability of Demodex folliculorum and Demodex brevis”. Parasitol Res 2009; 105: 1623-1628.

  16. Borgo SN, Sattler EC, Hogardt M, Adler K, Plewig G. “PCR analysis for Wolbachia in human and canine Demodex mites”. Arch Dermatol Res 2009; 301: 747-752.

  17. Lacey N, Delaney S, Kavanagh K, et al. “Mite-related bacterial antigens stimulate inflammatory cells in rosacea”. Br J Dermatol 2007; 157: 474-481.

  18. Li J, O’Reilly N, Sheha H, et al. “Correlation between ocular Demodex infestation and serum immunoreactivity to Bacillus proteins in patients with Facial rosacea”. Ophthalmology 2010; 117: 870-877.

  19. Akilov OE, Smirnova NS. “Epidemiology of human demodicosis”. Triada Pharm Publications; 2001; 3: 65-74.

  20. Karincaoglu Y, Bayram N, Aycan O, Esrefoglu M. “The clinical importance of Demodex folliculorum presenting with nonspecifical facial signs and symptoms”. J Dermatol 2004; 31(10): 618-626.

  21. Forton F, Seys B, Marchal JL, Song AM. “Demodex folliculorum and topical treatment: Acaricidal action evaluated by standardized skin surface biopsy”. Br J Dermatol, 1998; 138: 461-466.

  22. Kocak M, Yaglı S, Vahapoglu G, Eksioglu M. “Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study”. Dermatology, 2002;205(3):265-270.

  23. Forton F, Seys B, Marchal JL, Song AM. “Demodex folliculorum and topical treatment: acaricidal action evaluated by standardized skin surface biopsy”. Br J Dermatol 1998; 138: 461-466.

  24. Dourmishev AL, Dourmishev LA, Schwartz RA. “Ivermectin: pharmacology and application in dermatology”. Int J Dermatol 2005; 44: 981-988.

  25. Rodríguez Acar M, Morales Sánchez MA. “Demodecidosis papular primaria en edad pediátrica”. Dermatología Rev Mex 2008; 52(3): 130-133

  26. Hojyo Tomoka MT, Domínguez Soto L. “Demodecidosis and rosaceiform dermatitis”. Med Cutan Ibero Lat Am. 1976; 4(2): 83-90.




2020     |     www.medigraphic.com